298 related articles for article (PubMed ID: 17073742)
21. Human-specific expression of Siglec-6 in the placenta.
Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
[TBL] [Abstract][Full Text] [Related]
22. Siglecs that Associate with DAP12.
Angata T
Adv Exp Med Biol; 2020; 1204():215-230. PubMed ID: 32152949
[TBL] [Abstract][Full Text] [Related]
23. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
24. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
[TBL] [Abstract][Full Text] [Related]
25. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
Avril T; Freeman SD; Attrill H; Clarke RG; Crocker PR
J Biol Chem; 2005 May; 280(20):19843-51. PubMed ID: 15769739
[TBL] [Abstract][Full Text] [Related]
26. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
[TBL] [Abstract][Full Text] [Related]
27. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
28. Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937.
Mitsuki M; Nara K; Yamaji T; Enomoto A; Kanno M; Yamaguchi Y; Yamada A; Waguri S; Hashimoto Y
Glycobiology; 2010 Mar; 20(3):395-402. PubMed ID: 20032046
[TBL] [Abstract][Full Text] [Related]
29. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
[TBL] [Abstract][Full Text] [Related]
31. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
Crocker PR
Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
[TBL] [Abstract][Full Text] [Related]
32. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.
Zhang J; Raper A; Sugita N; Hingorani R; Salio M; Palmowski MJ; Cerundolo V; Crocker PR
Blood; 2006 May; 107(9):3600-8. PubMed ID: 16397130
[TBL] [Abstract][Full Text] [Related]
33. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H.
Blasius AL; Colonna M
Trends Immunol; 2006 Jun; 27(6):255-60. PubMed ID: 16679063
[TBL] [Abstract][Full Text] [Related]
34. Basic and clinical immunology of Siglecs.
von Gunten S; Bochner BS
Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
[TBL] [Abstract][Full Text] [Related]
35. Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers.
Lin CH; Yeh YC; Yang KD
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):5-24. PubMed ID: 31882261
[TBL] [Abstract][Full Text] [Related]
36. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.
Hara H; Ishihara C; Takeuchi A; Imanishi T; Xue L; Morris SW; Inui M; Takai T; Shibuya A; Saijo S; Iwakura Y; Ohno N; Koseki H; Yoshida H; Penninger JM; Saito T
Nat Immunol; 2007 Jun; 8(6):619-29. PubMed ID: 17486093
[TBL] [Abstract][Full Text] [Related]
37. New I-type lectins of the CD 33-related siglec subgroup identified through genomics.
Crocker PR; Zhang J
Biochem Soc Symp; 2002; (69):83-94. PubMed ID: 12655776
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor.
Walter RB; Häusermann P; Raden BW; Teckchandani AM; Kamikura DM; Bernstein ID; Cooper JA
Traffic; 2008 Feb; 9(2):267-79. PubMed ID: 18062779
[TBL] [Abstract][Full Text] [Related]
39. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.
Borges L; Hsu ML; Fanger N; Kubin M; Cosman D
J Immunol; 1997 Dec; 159(11):5192-6. PubMed ID: 9548455
[TBL] [Abstract][Full Text] [Related]
40. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
Daëron M; Jaeger S; Du Pasquier L; Vivier E
Immunol Rev; 2008 Aug; 224():11-43. PubMed ID: 18759918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
